The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast
β Scribed by Richard J. Santen; Samuel A. Wells Jr.
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 794 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The high rate of incidence of skeletal complications in women with metastatic breast carcinoma appears to contribute significantly to their morbidity. although recent trials have demonstrated the efficacy of bisphosphonates in preventing skeletal complications in selected patients, t
## Background: Tamoxifen commonly is used as adjuvant therapy for all stages of breast carcinoma. however, several studies have suggested an association between the use of tamoxifen in breast carcinoma patients and the subsequent development of endometrial carcinoma. the objective of this study was
## Abstract ## PURPOSE The authors conducted a singleβinstitution Phase I clinical trial to determine the maximum tolerated doses and to define the toxic effects of oral eniluracil and oral 5βfluorouracil (5βFU) combined with docetaxel in patients with metastatic breast carcinoma. ## PATIENTS AND